Navigation Links
Promising drug combination may help those with ocular melanoma that has spread
Date:9/4/2007

Uveal melanoma affects about 5,000 to 10,000 people each year in the United States. Unlike its counterpart on the skin, there are no known risk factors, Gollob said.

There are really no truly effective treatments for this devastating disease, he said. So this study really is a promising step toward finding a therapy that can really help these patients.

Uveal melanoma originates in the colored part of the eye, and symptoms include changes in vision, such as blurriness. If found early, it can be treated with radiation or with removal of the eye. When it spreads, uveal melanoma is typically unresponsive to standard treatment regimens, such as chemotherapy, Gollob said. Life expectancy once the disease has spread is about six to ten months, on average, he said.


'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. A promising treatment for wart removal
4. Hepatitis shots is promising
5. Promising Treatment for Diabetes
6. Life after Bypass not so Promising for Women.
7. Promising cure for West Nile Virus
8. Deadly Diarrhoea Vaccine – Trail Results Promising
9. Novartis MS Drug Shows Promising Results
10. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
11. Research Ethics Requirements Compromising Quality of Health Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... National Non-profit Launches Age-related Macu... at No Cost to Eligible Patients and Free Eye-Heal...isco, CA (Vocus) December 2, 2008 -- "Do You ...an eye disease known as Age-related Macular Degene..., , , , ,Picture this…. a large black hole...
(Date:12/2/2008)...wire-FirstCall/ -- Motorola, Inc. (NYSE: MOT ),...erbroadband system to enable,three hospitals mana...r,Generale de Sante to deliver voice, data and v...rovides an advanced IP broadband infrastructure to...xisting telephone line, eliminating,the need for ...
(Date:12/1/2008)... & Allergy Friendly, Toy Puppies to the Obama ...e-USNewswire/ -- Much has been made of President-E...But concerns about his daughter,s asthma and aller...ad from making a decision. So, in the meantime, t... is donating 2 "asthma & allergy friendly" toy...
(Date:12/1/2008)...s found that positron emission mammography (PEM), ...ected by either breast density or a woman,s hormon...s of standard mammography and MRI at detecting can... meeting of the Radiological Society of North Amer...er does not appear to be adversely affected by bre...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:New mammography technology effective in detecting breast cancer 2
...Biotechnologies, Inc., a wholly-owned subsidiary o... novel powder-based vaccine delivery technology m...uenza pandemic preparedness which were discussed b...ol of Influenza VI Conference" held in Toronto, Ca...
...r US vice president and presently a high profile e...rally, across the world Saturday next. He is behin... pop and rock music featuring various artists plan...7, 2007 to promote action to confront the global w...
...ithstanding, violent hate crimes on the rise again... Nearly four in 10 gay men and about one in eight ...een the target of violence or a property crime bec...ientation, according to a new study. "This is the...
...the abattoir, especially because it is afflicted w...m the mad cow disease that took a heavy toll of t...-year-old Freisian bull to the slaughterhouse is b...t" Hindus of Carmarthenshire, a tiny hamlet in Wal...
Other Medicine News:Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 2Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 3Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 2Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 3Health News:Hate Crimes Against Gays and Lesbians Rising in US 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2
(Date:12/1/2008)... Md., Dec. 1 Vanda Pharm...ion in The Lancet , one of the world,s leading me...novel circadian regulator, experimental compound t...am et al(1) is entitled "Melatonin agonist tasimel...time shift: two randomised controlled multicentre ...
(Date:12/1/2008)...IS, Dec. 1 Roche announced today t...ferences in perceived pain and,discomfort associa...ood,glucose monitoring systems and lancing device...cated that, overall, the ACCU-CHEK Aviva and ACCU-...s and the ACCU-CHEK Multiclix, ACCU-CHEK,Softclix...
(Date:12/1/2008)...inence is still the best policy , , ROCHES...w study from Mayo Clinic finds the use of the drug...lic hepatitis, an acute inflammation of the liver ...sults of the study are published in the December i...nal.org/ ). , , VIDEO ALERT: Additional au...
(Date:12/1/2008)...nce Call Scheduled for Tuesday, December 9 at 11:0... , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ..., Inc. (Nasdaq: SNSS ), a biopharmaceutical comp...on of new oncology therapeutics, today announced n...loid leukemia (AML) will be presented during the 5...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3A bees future as queen or worker may rest with parasitic fly 4223 1A bees future as queen or worker may rest with parasitic fly 4223 2Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 1Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 2Healthcare Executives Well Rewarded for Their Work 24431 1Healthcare Executives Well Rewarded for Their Work 24431 2Hypnosis shown to reduce symptoms of dementia 24427 1
...cokinetics and Dose Proportionality of,Company,s O...tics,Journal -, LAVAL, QC, June 29, 2007 /PRNewswi...t it will present a poster discussing the dose,tit...t the 3rd,International Forum on Pain Medicine to ...a. , The poster compares two different titration s...
...2007: Chi-Med, the Hutchison Whampoa backed pharma...itive results for its Phase II,proof-of-concept st...litis, a form of inflammatory bowel disease. The ...tolerated and showed an,equivalent drop in clinica..., the current first-line standard of care in,mild-...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8
The Anterior Isola System is intended for use in correcting scoliotic, lordotic or kyphotic spinal deformities by establishing an axially stiff fixation bridge parallel to the long axis of the spine.
...Bowman Perfusion Monitor measures focal tissue per.... This precision instrument activates the minimall... connected by an umbilical cord to collect the dat... a host PC via serial port for processing, storage...
The Laserflo BPM2 is designed to give accurate and continuous cerebral blood flow data in neurosurgical intensive care, trauma, and operating room settings. The system is safe and easy to use, and pr
Oxyflo is a highly featured laser doppler system for continuous monitoring of microvascular blood perfusion from multiple tissue sites. This latest generation system incorporates developments in Digi
Medicine Products: